Science

Feb 16, 2025, 11:14

Myeloma Paper of the Day, February 16th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Observational multicenter Italian study to analyze the profile of myeloma patients who survived 10 years or longer finds age >60, hypoalbuminemia dx, of anti-myeloma therapies equal or >3 as significant prognostic factors.”

“Long-Term Survival with Multiple Myeloma: An Italian Experience”

Authors: Francesca Fazio, Martina Gherardini, Elena Rossi, Maurizio Martelli, Maria Teresa Petrucci et al.

More posts featuring Robert Orlowski.

cancer Elena Rossi Francesca Fazio Maria Teresa Petrucci Martina Gherardini Maurizio Martelli multiple myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology